Tissue plasminogen activator and thrombin generation measurements using the Thrombinoscope

Blood Coagulation and Fibrinolysis

Volumn 17, Issue 7, 2006, Pages 603-604

  Szlam, Fania ^a   Levy, Jerrold H ^a   Tanaka, Kenichi A ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROCOAGULANT; THROMBIN; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR;

AUTOANALYSIS; CONCENTRATION RESPONSE; DEVICE; ENZYME SUBSTRATE; FLUORESCENCE ANALYSIS; HEART INFARCTION; HYPERCOAGULABILITY; LETTER; PRIORITY JOURNAL; STROKE; THROMBIN TIME; THROMBOCYTE FREE PLASMA; THROMBOCYTE POOR PLASMA; THROMBOCYTE RICH PLASMA;

BLOOD COAGULATION TESTS; COUMARINS; HUMANS; OLIGOPEPTIDES; SENSITIVITY AND SPECIFICITY; THROMBIN; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 33748948416     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000245296.87515.fd     Document Type: Letter

References (8)

1. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33:4-15.
2. Faber CG, Lodder J, Kessels F, Troost J. Thrombin generation in platelet-rich plasma as a tool for the detection of hypercoagulability in young stroke patients. Pathophysiol Haemost Thromb 2003; 33:52-58.
3. Gerotziafas GT, Depasse F, Chakroun T, Van Dreden P, Samama MM, Elalamy I. Comparison of the effect of fondaparinux and enoxaparin on thrombin generation during in-vitro clotting of whole blood and platelet-rich plasma. Blood Coagul Fibrinolysis 2004; 15:149-156.
4. Iwanaga S, Morita T, Kato H, Harada T, Adachi N, Sugo T, et al. Fluorogenic peptide substrates for proteases in blood coagulation, kallikrein-kinin and fibrinolysis systems. Adv Exp Med Biol 1979; 120A:147-163.
5. Guo M, Mathieu PA, Linebaugh B, Sloane BF, Reiners JJ Jr. Phorbol ester activation of a proteolytic cascade capable of activating latent transforming growth factor-betaL a process initiated by the exocytosis of cathepsin B. J Biol Chem 2002; 277:14829-14837.
6. Tebbe U, Tanswell P, Seifried E, Feuerer W, Scholz KH, Herrmann KS. Single-bolus injection of recombinant tissue-type plasminogen activator in acute myocardial infarction. Am J Cardiol 1989; 64:448-453.
7. Modi NB, Eppler S, Breed J, Cannon CP, Braunwald E, Love TW. Pharmacokinetics of a slower clearing tissue plasminogen activator variant, TNK-tPA, in patients with acute myocardial infarction. Thromb Haemost 1998; 79:134-139.
8. Hu CK, Kohnert U, Sturzebecher J, Fischer S, Llinas M. Complexation of the tissue plasminogen activator protease with benzamidine-type inhibitors: interference by the kringle 2 module. Biochemistry 1996; 35:3270-3276.